Metabolic-Fit / 100
Corsica Health review
Rare for showing compounded AND brand-name pricing on the same page — semaglutide from $149/mo, tirzepatide from $249/mo on 3-month plans, flat $1,499/mo brand options — but nothing addresses PCOS or postpartum metabolic changes, and its own FAQ quotes a stale price the live checkout has already undercut.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Corsica Health at a glance
- Semaglutide
- $249/mo month-to-month ($149/mo on the 3-month plan)
- Tirzepatide
- $349/mo month-to-month ($249/mo on the 3-month plan)
- Coverage
- Not disclosed — no published state list
- Brand-name
- Yes
How we scored Corsica Health
Every factor comes from Corsica Health's own published pricing, disclosures and oversight, and the six combine into the 42/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.joincorsica.com/products.json
$249 for semaglutide and $349 for tirzepatide month to month, dropping to $149 and $249 on the three-month plan — figures read from the store's own checkout data rather than its marketing copy. No state list is published.
What to expect when you sign up
We walked Corsica Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Complete an online health assessment
- 2A licensed provider reviews it, typically within 24 hours
- 3If approved, medication ships within a few days
What we noticed
- Publishes both compounded AND brand-name pricing side by side on one site — unusual transparency for this category
- The site's own FAQ says plans 'start at $249/month' while the actual product checkout data shows $149/mo on the 3-month semaglutide plan — I used the live checkout numbers, not the stale FAQ line
- Brand-name Wegovy, Ozempic, Mounjaro, and Zepbound are all listed at a flat $1,499/mo
- Nothing on the site addresses PCOS, pregnancy, breastfeeding, or postpartum timing
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $149 | 3-Month Plan (40% off)Billed $447 upfront for 3 months. Live-checked against joincorsica.com/products.json August 4, 2026. |
| Compounded semaglutide | $249 | 1-Month PlanMonth-to-month, no commitment. |
| Compounded tirzepatide | $249 | 3-Month Plan (28% off)Billed $747 upfront for 3 months. |
| Compounded tirzepatide | $349 | 1-Month PlanMonth-to-month, no commitment. |
| Brand semaglutide | $1499 | Wegovy / Ozempic (branded) |
| Brand tirzepatide | $1499 | Mounjaro / Zepbound (branded) |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Corsica Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Publishes both compounded and brand-name pricing on one site — unusual transparency
- Brand-name Wegovy, Ozempic, Mounjaro, and Zepbound all at $1,499/mo, below typical cash-pay retail
- 3-month plans meaningfully lower the monthly price versus paying month-to-month
- Provider review typically turns around within 24 hours, per the site
The caveats
- Nothing addresses PCOS, hormonal fit, pregnancy, or breastfeeding
- The site's own FAQ ('$249/month') is stale against the live checkout price ('$149/month') — confirm the number you're actually being charged
- No state list, no legal entity name, and no named compounding pharmacy
- No first-month promotional pricing disclosed — treat the listed price as the real one
Corsica Health for mothers: our verdict
Rare for showing compounded AND brand-name pricing on the same page — semaglutide from $149/mo, tirzepatide from $249/mo on 3-month plans, flat $1,499/mo brand options — but nothing addresses PCOS or postpartum metabolic changes, and its own FAQ quotes a stale price the live checkout has already undercut. It runs about $249/month — a premium to the category, so the extras have to earn it.
We weigh Corsica Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Corsica Health costs, in full
- Compounded semaglutide — 3-Month Plan (40% off): $149/mo
- Compounded semaglutide — 1-Month Plan: $249/mo
- Compounded tirzepatide — 3-Month Plan (28% off): $249/mo
- Compounded tirzepatide — 1-Month Plan: $349/mo
- Brand-name semaglutide — Wegovy / Ozempic (branded): $1499/mo
- Brand-name tirzepatide — Mounjaro / Zepbound (branded): $1499/mo
For context, the typical ongoing price across our roster is around $179/month, so Corsica Health sits at the premium end.
Corsica Health says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Corsica Health prescribes
Corsica Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
Where Corsica Health fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Corsica Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants the option to step up to real FDA-approved brand medication without switching providers, without needing PCOS-specific programming.
Alternatives to Corsica Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Corsica Health
Head-to-head & alternatives
Corsica Health, answered
- Why does the FAQ say $249 but the pricing table says $149?
- The site's own FAQ text looks stale — the actual checkout data shows the 3-month semaglutide plan at $149/mo, billed $447 upfront. I used the real checkout number, since that's the price you'd actually be charged.
- Does Corsica Health address PCOS or hormonal health?
- No — nothing on the site addresses PCOS, hormonal fit, pregnancy, or breastfeeding. It's a general compounded/brand GLP-1 platform, not a metabolic-health specialist for mothers.
- Does Corsica Health offer FDA-approved brand medication?
- Yes — Wegovy, Ozempic, Mounjaro, and Zepbound are all listed at a flat $1,499/mo alongside the compounded options, genuinely below typical cash-pay retail for brand GLP-1s.
Pricing, states and verification reflect Corsica Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.